New and Old Molecules in the Fight Against Multi-resistant Bacteria
Marinelli, Flavia, Genilloud, Olga (Eds.)
2014, VIII, 364 p. 71 illus., 10 illus. in color.
Springer SmartBook is the new eBook generation. You can read Springer Smartbooks on any smartphone, tablet or laptop/desktop machine. Smartbooks are optimized for Smartphones and Tablets. Find further information on www.springer.com/smartbooks
You can pay for Springer Smartooks with Visa, Mastercard, American Express or Paypal.
After the purchase you can directly access the Smartbook via Online Reader. The access is valid infinitely. For security reasons you need only to login before reading your Smartbook online
price for USA
includes note taking, highlight and search functionality, might contain videos, glossary and quizzes
Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.
You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.
After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.
Examines the latest developments in antibacterial research and drug design
Integrates basic and clinical aspects
Written by international experts
Reports on the emergence and prevalence of resistant bacterial infections in hospitals and communities raise concerns that we may soon no longer be able to rely on antibiotics as a way to control infectious diseases. Effective medical care would require the constant introduction of novel antibiotics to keep up in the “arms race” with resistant pathogens.
This book closely examines the latest developments in the field of antibacterial research and development. It starts with an overview of the growing prevalence of resistant Gram-positive and Gram-negative pathogens, including their various resistance mechanisms, prevalence, risk factors and therapeutic options. The focus then shifts to a comprehensive description of all major chemical classes with antibacterial properties, their chemistry, mode of action, and the generation of analogs; information that provides the basis for the design of improved molecules to defeat microbial infections and combat the emerging resistances. In closing, recently developed compounds already in clinical use, those in preclinical or first clinical studies, and a number of promising targets to be exploited in the discovery stage are discussed.